BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18486616)

  • 1. Unraveling the role of PD-1/PD-L interactions in persistent hepatotropic infections: potential for therapeutic application?
    Radziewicz H; Hanson HL; Ahmed R; Grakoui A
    Gastroenterology; 2008 Jun; 134(7):2168-71. PubMed ID: 18486616
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
    Nakamoto N; Kaplan DE; Coleclough J; Li Y; Valiga ME; Kaminski M; Shaked A; Olthoff K; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
    Gastroenterology; 2008 Jun; 134(7):1927-37, 1937.e1-2. PubMed ID: 18549878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the PD-1/PD-L1 pathway in immunopathology of HBV infection as the chance on the new therapeutic strategy].
    Gołabek V; Woźniakowska-Gesicka T
    Przegl Epidemiol; 2010; 64(4):485-9. PubMed ID: 21473062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.
    Evans A; Riva A; Cooksley H; Phillips S; Puranik S; Nathwani A; Brett S; Chokshi S; Naoumov NV
    Hepatology; 2008 Sep; 48(3):759-69. PubMed ID: 18697210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1(+)/CD127(-) HCV-specific CD8(+) cells targeting the virus in chronic hepatitis C virus infection.
    Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; González-Praetorius A; Albertos S; García-Garzón S; Lokhande M; Parra-Cid T
    Cell Immunol; 2011; 269(2):104-14. PubMed ID: 21481848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
    Yao ZQ; King E; Prayther D; Yin D; Moorman J
    Viral Immunol; 2007; 20(2):276-87. PubMed ID: 17603844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.
    Radziewicz H; Ibegbu CC; Fernandez ML; Workowski KA; Obideen K; Wehbi M; Hanson HL; Steinberg JP; Masopust D; Wherry EJ; Altman JD; Rouse BT; Freeman GJ; Ahmed R; Grakoui A
    J Virol; 2007 Mar; 81(6):2545-53. PubMed ID: 17182670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.
    Golden-Mason L; Palmer B; Klarquist J; Mengshol JA; Castelblanco N; Rosen HR
    J Virol; 2007 Sep; 81(17):9249-58. PubMed ID: 17567698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
    Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
    Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.
    Boni C; Fisicaro P; Valdatta C; Amadei B; Di Vincenzo P; Giuberti T; Laccabue D; Zerbini A; Cavalli A; Missale G; Bertoletti A; Ferrari C
    J Virol; 2007 Apr; 81(8):4215-25. PubMed ID: 17287266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
    Vali B; Jones RB; Sakhdari A; Sheth PM; Clayton K; Yue FY; Gyenes G; Wong D; Klein MB; Saeed S; Benko E; Kovacs C; Kaul R; Ostrowski MA
    Eur J Immunol; 2010 Sep; 40(9):2493-505. PubMed ID: 20623550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.
    Peng G; Li S; Wu W; Tan X; Chen Y; Chen Z
    Mol Immunol; 2008 Feb; 45(4):963-70. PubMed ID: 17868872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients.
    Shi F; Shi M; Zeng Z; Qi RZ; Liu ZW; Zhang JY; Yang YP; Tien P; Wang FS
    Int J Cancer; 2011 Feb; 128(4):887-96. PubMed ID: 20473887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome.
    Kasprowicz V; Schulze Zur Wiesch J; Kuntzen T; Nolan BE; Longworth S; Berical A; Blum J; McMahon C; Reyor LL; Elias N; Kwok WW; McGovern BG; Freeman G; Chung RT; Klenerman P; Lewis-Ximenez L; Walker BD; Allen TM; Kim AY; Lauer GM
    J Virol; 2008 Mar; 82(6):3154-60. PubMed ID: 18160439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B.
    Chen J; Wang XM; Wu XJ; Wang Y; Zhao H; Shen B; Wang GQ
    Inflamm Res; 2011 Jan; 60(1):47-53. PubMed ID: 20661763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B].
    Xie DY; Lin BL; Chen FJ; Deng H; Chong YT; Zhang XH; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):646-50. PubMed ID: 20943073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
    Missale G; Pilli M; Zerbini A; Penna A; Ravanetti L; Barili V; Orlandini A; Molinari A; Fasano M; Santantonio T; Ferrari C
    Gut; 2012 Jul; 61(7):1076-84. PubMed ID: 22337949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 modulates regulatory T cells and suppresses T-cell responses in HCV-associated lymphoma.
    Ni L; Ma CJ; Zhang Y; Nandakumar S; Zhang CL; Wu XY; Borthwick T; Hamati A; Chen XY; Kumaraguru U; Moorman JP; Yao ZQ
    Immunol Cell Biol; 2011 May; 89(4):535-9. PubMed ID: 20975732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection.
    Watanabe T; Bertoletti A; Tanoto TA
    J Viral Hepat; 2010 Jul; 17(7):453-8. PubMed ID: 20487259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.